Dexmedetomidine
From Wikipedia, the free encyclopedia
 |
|
|
Dexmedetomidine
|
|
| Systematic (IUPAC) name | |
| 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole | |
| Identifiers | |
| CAS number | |
| ATC code | N05 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C13H16N2 |
| Mol. mass | 200.28 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 94% |
| Metabolism | ? |
| Half life | 2 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Dexmedetomidine is a sedative medication used by intensive care units and anesthesiologists. It is relatively unique in its ability to provide sedation without causing respiratory depression. Like clonidine, its mechanism of action is agonism of alpha-2 receptors in certain parts of the brain.[1]
Dexmedetomidine has sedative, analgesic, sympatholytic, and anxiolytic effects that blunt many of the cardiovascular responses in the perioperative period. It reduces the volatile anesthetic, sedative and analgesic requirements of the patient without causing significant respiratory depression.[2]
Recent research has suggested dexmedetomidine to be an effective treatment for the dangerous cardiovascular symptoms of cocaine intoxication and overdose.[3] It also seemed to be superior to lorazepam for ventilated patients in the intensive care unit.[4]
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
[edit] References
- ^ Cormack JR, Orme RM, Costello TG. The role of alpha2-agonists in neurosurgery. Journal of Clinical Neuroscience. 2005 May;12(4):375-8.
- ^ Paris A, Tonner PH. Dexmedetomidine in anaesthesia. Current Opinion in Anaesthesiology. 2005 Aug;18(4):412-8.
- ^ Menon DV, Wang Z, Fadel PJ, Arbique D, Leonard D, Li JL, Victor RG, Vongpatanasin W. "Central sympatholysis as a novel countermeasure for cocaine-induced sympathetic activation and vasoconstriction in humans". J Am Coll Cardiol 2007; 50(7): 626-33. PMID 17692748
- ^ Pandharipande PP, Pun BT, Herr DL, et.al. "Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial." JAMA 2007; 298(22): 2644-53. PMID 18073360
